The disaffection with 3rd and 4th generation pills, which began in 2013, has continued and has benefited less risky pills for women's health, the National Medicines Safety Agency (ANSM) welcomed on Friday. and Public Health France.
The controversy over the risk of 3rd and 4th generation pills was launched in January 2013 after the complaint of a victim of a cerebrovascular accident (stroke) attributed to a 3rd generation pill.
Covid-19: the third vaccine dose, instructions for use
Read also Does the cost of hormonal contraception explain its decline in France?
The drug agency had to renew its recommendations on these pills, which should only be prescribed as a second resort because of the increased risk of venous thrombosis (phlebitis) they cause.
However, the latest sales data show that the postponement of prescriptions for 3rd and 4th generation contraceptive pills to 1st and 2nd generation pills, which began in 2013, continued, ANSM announced on Friday, shortly before World Contraception Day. , September 26.
"A change in practices that is sustainable"
At the time of the strong media debate on the pills in 2012-2013, more than 50% of the most thrombogenic pills were used
", that is to say likely to cause venous thrombosis, detailed to AFP Isabelle Yoldjian director of drugs in gynecology at the ANSM.
Today we mainly use, at 86%, the least thrombogenic second-generation pills, against 14% for the most thrombogenic pills
Practitioners are well trained in the risk because they mostly prescribe the best tolerated pills, it is a change in practices that is part of the long term,
" she said.
Read also The main dates of contraception in France
At the same time, sales of copper IUDs (without hormones) have doubled over the past ten years, while sales of hormonal IUDs have remained stable.
transformation of the contraceptive landscape is a step in the right direction for patient safety
," said Ms. Yoldjian.
At the beginning of the year, Public Health France launched a site, Questionsexualité.fr, which presents all methods of contraception.
There is "
the advantages, disadvantages, modes of use, and practical information that allows you to choose from the existing offer,
" said Delphine Rahib, researcher in sexual health at SPF.